Royal Sense Ltd — Important, 20-05-2026: Company Update

Royal Sense expanded its product portfolio by launching seven new items for the domestic market. These include a range of pharmaceuticals for infections, anxiety, pain management, and sleep disorders, alongside a digital blood pressure monitor. The new pharmaceutical offerings target significant markets, like the Anti-Infective segment valued at over ₹20,000 Crore and the CNS segment at ₹18,000-25,000 Crore. The BP monitor enters India's rapidly growing medical device market, estimated at ₹90,000-1,10,000 Crore, enhancing the company's presence in key healthcare areas.